How to prove whether Huanglian Wendan Tang is effective in diabetes with non-alcoholic fatty liver disease? At present, there is a lack of large-scale clinical observation and research on the application effect of Huanglian Wendan Tang in diabetes patients with nonalcoholic fatty liver. The purpose of this study was to observe the effect of Huanglian Wendan Tang in patients with diabetes and non-alcoholic fatty liver disease. This article recruited a total of 60 cases that met the inclusion criteria, of which 30 patients received Huanglian Wendan Tang treatment (experimental group), and the other 30 patients received conventional treatment (control group). The experimental group patients took Huanglian Wendan Tang orally, three times a day, and received continuous treatment for four weeks. Two groups of patients underwent clinical examinations and evaluation of laboratory indicators before and after treatment. After several experimental tests, it was found that patients in the experimental group showed significant improvements after treatment. After taking Huanglian Wendan Tang continuously for one month, the blood sugar decreased from 12.85mmol/L to 8.6mmol/L, which can effectively lower the blood sugar in the patient's body.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: